Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy

被引:68
作者
Le Guellec, C
Büchler, M
Giraudeau, B
Le Meur, Y
Gakoué, JE
Lebranchu, Y
Marquet, P
Paintaud, G
机构
[1] Tours Univ Hosp, Dept Pharmacol, F-37044 Tours, France
[2] Tours Univ Hosp, Dept Nephrol & Clin Immunol, F-37044 Tours, France
[3] Univ Tours, Haematopiet Stem Cells & Haemostatis Transplantat, F-37041 Tours, France
[4] Univ Tours, Dept Clin Res, F-37041 Tours, France
[5] Limoges Univ Hosp, Dept Nephrol, Limoges, France
[6] Limoges Univ Hosp, Dept Pharmacol & Toxicol, Limoges, France
关键词
cyclosporin; mycophenolic acid; drug monitoring; limited sampling strategy;
D O I
10.1007/S00228-001-0389-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Area under the curve (AUC)-based monitoring of cyclosporin (CsA) could help to optimise therapeutic drug monitoring in certain transplant patients in addition to trough concentration monitoring. It is the method of choice for mycophenolic acid (MPA). The objective of this study was to develop a limited sampling strategy for simultaneous estimation of CsA and MPA AUCs in long-term renal transplant patients. Methods: Twenty kidney transplant patients treated with CsA and mycophenolate mofetil were included in a pharmacokinetic study more than 6 months after transplantation. Multilinear regression analyses were performed to develop a model enabling the estimation of both drugs' AUCs using a limited number of samples. Dose-normalised data were used throughout the analysis. Results: Trough concentrations of MPA were poorly correlated with AUC, either used alone (r(2) = 0.232) or together with other concentrations. Several models for CsA AUC estimation met the predefined criteria (r(2) > 0.9, P < 0.05). The AUC of MPA was best estimated by a three-concentration model (AUC = 0.58 C-20 min + 0.97 C-1 (h) + 6.64 C-3 (h) + 3.48; r(2) = 0.946). These sampling times also applied to CsA AUC 2 (AUC = 1.17 C-20 min, + 0.68 C-1 (h) + 5.36 C-3 (h) + 4.24; r(2) =0.985). AUCs estimated using these models in our patients using the jack-knife procedure were found to be precise and unbiased as compared with reference trapezoidal AUCs. Conclusion: We were able to develop a multilinear regression model for simultaneous estimation of both CsA and MPA AUCs using only three blood samples taken up to 3 h post-dosing.
引用
收藏
页码:805 / 811
页数:7
相关论文
共 30 条
[1]   Clinical pharmacokinetics of mycophenolate mofetil [J].
Bullingham, RES ;
Nicholls, AJ ;
Kanmm, BR .
CLINICAL PHARMACOKINETICS, 1998, 34 (06) :429-455
[2]  
Bullingham RES, 1996, TRANSPLANT P, V28, P925
[3]   CYCLOSPORINE PLASMA-LEVELS 6 HOURS AFTER ORAL-ADMINISTRATION - A USEFUL TOOL FOR MONITORING THERAPY [J].
CANTAROVICH, F ;
BIZOLLON, C ;
CANTAROVICH, D ;
LEFRANCOIS, N ;
DUBERNARD, JM ;
TRAEGER, J .
TRANSPLANTATION, 1988, 45 (02) :389-394
[4]   Comparison of neoral dose monitoring with cyclosporine trough levels versus 2-hr postdose levels in stable liver transplant patients [J].
Cantarovich, M ;
Barkun, JS ;
Tchervenkov, JI ;
Besner, JG ;
Aspeslet, L ;
Metrakos, P .
TRANSPLANTATION, 1998, 66 (12) :1621-1627
[5]   Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: Review of current algorithms [J].
David, OJ ;
Johnston, A .
THERAPEUTIC DRUG MONITORING, 2001, 23 (02) :100-114
[6]  
Davies POAL, 2000, IMECHE SEM, V2000, P39
[7]   Methods for clinical monitoring of cyclosporin in transplant patients [J].
Dumont, RJ ;
Ensom, MHH .
CLINICAL PHARMACOKINETICS, 2000, 38 (05) :427-447
[8]   Abbreviated kinetic profiles in area-under-the-curve monitoring of cyclosporine therapy - Technical Note [J].
Gaspari, F ;
Perico, N ;
Signorini, O ;
Caruso, R ;
Remuzzi, G .
KIDNEY INTERNATIONAL, 1998, 54 (06) :2146-2150
[9]   The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation [J].
Hale, MD ;
Nicholls, AJ ;
Bullingham, RES ;
Hené, R ;
Hoitsma, A ;
Squifflet, JP ;
Weimar, W ;
Vanrenterghem, Y ;
Van de Woude, FJ ;
Verpooten, GA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (06) :672-683
[10]  
INGRAM D, 1984, STAT ANAL TECHNIQUES, P12